Peer Review History

Original SubmissionDecember 22, 2020
Decision Letter - Bidhubhusan Mahapatra, Editor

PONE-D-20-40284

Association between biological sex and insecticide-treated net use among household members in ethnic minority and internally displaced populations in eastern Myanmar

PLOS ONE

Dear Dr. Davison,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The paper needs more careful review of statistical analyses and justification around the use of data from 2013.

Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact.

Please submit your revised manuscript by Apr 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Bidhubhusan Mahapatra, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In statistical methods, please refer to any post-hoc corrections to correct for multiple comparisons during your statistical analyses. If these were not performed please justify the reasons. Please refer to our statistical reporting guidelines for assistance (https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting).

3. In your statistical analyses, please state whether you accounted for clustering by locality. For example, did you consider using multilevel models?

4.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 0 in your text; if accepted, production will need this reference to link the reader to the Table.

6. Please include a copy of Table 3 which you refer to in your text on page 12.

Additional Editor Comments:

This is an interesting area of work. While there is value in this work, there are certain areas where the authors need to work to strengthen the paper. First, the paper needs a strong justification on why you are using data from 2013? Given the development that has taken place in Myanmar in last few years, does this data still hold significance? Please include justification around it. Second, the statistical analyses need a thorough review. I have noticed several errors across the tables. to give a few example: the 95% CIs are not consistent with the point estimates in Table 1 for age 50+ (did not use ITN). Also, in Table 2, Lives in household with sufficient ITN supply for comparison by sex of HH member, the 95% Cis overlap, but p-value is 0.03 which does not look correct. Some of other minor observations are:(i) How the missing values were treated in the analysis? (ii) Multivariable analysis instead of multivariate analysis, (iii) give more clarity on the sampling of households, (iv) why local IRB approval was not taken for this study? (v) Who was responsible for collecting data and when exactly data was collected, give clarity around it? Clarify if the duration of data collection had any effect on the ITN use or other survey measures? (vi) Rename Table 0 as Table 3? (vii) Include interaction analysis result in the table, (viii) In the discussion line 271, you suggest that ITN use was self-reported. Does it mean all HH members were asked questions oon ITN use? If not, then change it accordingly. (ix) A key limitation is the use of a data that may not be representing the current situation. Suggest including this as a limitation.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors explored ITN access and use among a high risk migrant population in Myanmar using data from 2013. They demonstrate differences in ITN use by age and biologic sex and that pregnant women and children under five are prioritized to use ITNs. Their findings may potentially be used inform the distribution strategies and promote use of ITNs among this vulnerable population.

Major

The manuscript will hugely benefit from a detailed justification of their use of data from 2013, particularly given the change in malaria landscape since 2013. The authors note that Between 2010-2018, the number of reported malaria cases in the country declined by 76% and deaths fell by 95%. The context of the migrant population in Myanmar has also changed with the Rohingya crises and over one million people in need of humanitarian assistance. This manuscript would be bolstered significantly by the use of more recent data or a clear rationale for the use of such dated data, delineating how the study findings are still relevant in 2021. It would also be helpful to note any differences in the study population, ITN distribution channels and major factors influencing ITN access and use have changed from the time of the study to date. Of note, the study findings probably do not reflect the more recent shift to universal coverage of ITN ownership and use which may have occurred since 2013.

Minor

1. Overall

Current thinking as evidenced by the recent literature and global research such as Malaria Indicator Surveys, Demographic and Health Surveys and Multiple Indicator Cluster Surveys now highlight population level access to ITNs. I would encourage the authors include overall population level ITN access in their findings. Of note, while this indicator does not allow exploration of individual level factors, it might benefit the manuscript to show how the population level ITN access and potential differences by household or regional level factors. For more information on the methodology, see https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0097496: First, an intermediate variable of “potential ITN users” was created by multiplying the number of ITN in each household by a factor of 2.0. In order to adjust for households with more than one net for every two people, the potential ITN users were set equal to the de-facto population in that household if the potential users exceeded the number of people in the household. Second, the population access indicator was calculated by dividing the potential ITN users by the number of de-facto members for each household and determining the overall sample mean of that fraction.

2.Abstract and Introduction

Line 77-78. Consider revising the sentence: A key challenge to this goal is the effective use of ITNs. It reads as if the major challenge of the goal of using ITNs is the use of ITNs which is probably not what the authors intended.

3. Table 1

Some of the columns do not add up to 100%. I would recommend the authors make the characteristic- Other socio- demographic sub-groups- mutually exclusive by including an "other" category and revising the characteristic to "socio- demographic sub-groups".

Also, the final characteristic- household members- should be revised in order to add up to 100%.

4. Table 2

Include the p values for each of the other socio-demographic sub-groups

5. Discussion

As noted earlier, please discuss the dated findings in light of potential changes to the study population context, ITN distribution strategies, and factors influencing ITN access and use.

6. Conclusion

This is notably absent from the main text. Kindly include

Reviewer #2: This was a well-written paper examining a question that is of interest currently - namely the role of gender on ITN use. Also, Myanmar is a country about which little is known on the subject of malaria prevention. This paper provides some interesting insights.

Reviewer #3: 1. The abstract section needs to be revised and it should be as per PLOS One style and format

2. In Materials and methods section, in page 6: the authors can add Measures section before the variables used and dependent variable/outcome variable sub section and independent variable/explanatory variable section (effect modifiers and confounding variables) section should be created.

3. Again, it will be good if the authors can write detail description on the variables used in the analysis (like categories, definition etc.)

4. The current form of results and discussion section looks weak. If the additional analysis on prevalence of malaria in the region/geography can be added (for sex and geography), along with trend, pattern of malaria prevalence/incidence it will be good. Additionally, the association between ITN use and malaria prevalence/incidence will be very good for future policy and program enhancement and take away.

5. Without the revised results and analysis, the paper discussion section feels like half knowledge has been provided in the region. The discussion section needs to be strengthen with the revised analysis and findings. Then possibly the recommendations and conclusion can be better placed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We have attached a detailed response to reviewers chart.

Attachments
Attachment
Submitted filename: FINAL Response to Reviewers_PLOS One.docx
Decision Letter - Bidhubhusan Mahapatra, Editor

Association between biological sex and insecticide-treated net use among household members in ethnic minority and internally displaced populations in eastern Myanmar

PONE-D-20-40284R1

Dear Dr. Davison,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Bidhubhusan Mahapatra, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Bidhubhusan Mahapatra, Editor

PONE-D-20-40284R1

Association between biological sex and insecticide-treated net use among household members in ethnic minority and internally displaced populations in eastern Myanmar

Dear Dr. Davison:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Bidhubhusan Mahapatra

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .